Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Considering, Discussing And Approving Unaudited Financial Results Of The Company For The Quarter Ended 31St December, 2022.

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 27th January, 2023 at 2.00 p.m. through video conferencing and audio-visual means to transact inter - alia the following businesses: 1) To consider, discuss and approve Unaudited Financial Results of the Company for the quarter ended 31st December, 2022. 2) Any other matter with the permission of the Chair.
20-01-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder Certificate dated January 02, 2023 received from the SEBI Registered Registrar and Share Transfer Agent (RTA) viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended December 31, 2022.
03-01-2023
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

 Dear Sir / Madam, Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Sunday, 1st January, 2023 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the Quarter ended 31st December, 2022, would be considered, approved and declared. The said information is being notified to all designated persons under the above Regulations.
30-12-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Allotment Of 17,500 Equity Shares To Non-Promoters Upon Conversion Of Warrants Into Equity Shares

 This is to inform you that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extraordinary General Meeting held on September 23, 2023, allotment of convertible warrants on Preferential Basis to Non-Promoters was done on December 27, 2022. Further, we would like to inform that the Warrant Holders have paid the balance of the consideration aggregating to Rs. 87,16,750/- and have applied for exercising their rights for conversion of 17,500 warrants into equivalent number of Equity Shares. Consequently, the Board of Directors in its meeting held today i.e. December 27, 2022 has allotted 17,500 Equity Shares of face value Rs. 10/- each to the warrant holders
27-12-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 With reference to the captioned subject, this is to bring to your kind attention that the Company has received intimation on 21st December, 2022 from Purva Sharegistry (India) Pvt. Ltd, the Share Transfer Agent of the Company, pertaining to loss/ misplacement of Original Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original Share Certificates been lost. Sr. No. Name of the Shareholder Number of shares Folio No. Certificate No.(s) 1. Santosh Mathur 1000 000070 0001754- 0001763
22-12-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

 We wish to inform you that the Board of Directors of the Company at their meeting held on 13th December, 2022 have accorded their consent to shift the registered office of the Company from 26 Manoj Industrial Premises G. D Ambekar, Wadala, Mumbai 400031 to 11th Floor, Tower A, Urmi Estate 95, Ganpatrao Kadam Marg, Lower Parel (W) Mumbai-400013 i.e. within the local limits of City with effect from 13th December, 2022.
13-12-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 With reference to the captioned subject, this is to bring to your kind attention that the Company has received intimation on 30th November, 2022 from Purva Sharegistry (India) Pvt. Ltd, the Share Transfer Agent of the Company, pertaining to loss/ misplacement of Original Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original Share Certificates been lost.
01-12-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir / Madam, In compliance to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; we hereunder furnish a press release regarding receipt of multiple contracts from Southeast Asian country for Pharma exports. Kindly take the same on your Records.
28-11-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Revised Outcome Of Board Meeting Held On 10Th November, 2022

 Revised Outcome of Board Meeting: We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, 10th November, 2022 had considered and approved the following item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the half year and quarter ended 30th September, 2022 along with the Limited Review Report as issued by M/s Savla & Associates, Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 3:00 P.M. and concluded at 7:15 P.M.
11-11-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Revised Outcome Of The Board Meeting Held On 10Th November, 2022

 Revised outcome of the Board Meeting: We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, 10th November, 2022 had considered and approved the following item: 1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the half year and quarter ended 30th September, 2022 along with the Limited Review Report as issued by M/s Savla & Associates, Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 3:00 P.M. and concluded at 7:15 P.M.
11-11-2022
Next Page
Close

Let's Open Free Demat Account